Clinical Trial Update: Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies [NA]

View source ↗

Summary

A completed clinical trial evaluating intensity modulated total marrow irradiation (IM-TMI) for advanced hematologic malignancies, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Leukemia
• Lymphoblastic Leukemia
• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Acute Myeloid Leukemia, Lymphoblastic Leukemia | NA | Status: COMPLETED | Results posted: 2021-06-14